Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/BRIDGEBIO-PHARMA-INC-60342525/news/BridgeBio-Pharma-Presents-12-month-Results-from-Phase-2-Study-of-BBP-418-in-Limb-Girdle-Muscular-Dys-42019596/?utm_source=whatsapp&utm_medium=social&utm_campaign=share